The above published paper included two errors. The details of the errors and corrections follow.
On page 2 under Treatment, the sentence:
The initiation and build-up phase of treatment followed the manufacturer's specifications; it comprised a gradual escalation of doses over an 11-day period, followed by maintenance treatment of 1200 index of reactivity daily, over a 24-month period.
should read:
The initiation and build-up phase of treatment followed the manufacturer's specifications; it comprised a gradual escalation of doses over an 11-day period, followed by maintenance treatment of 120 index of reactivity daily, over a 24-month period.
On page 5, the sentence:
The dosing regimen in this study was in accordance with the manufacturer's recommendations: the total cumulative dose was 6610 index of reactivity during the build-up phase, followed by 1200 index of reactivity daily.
should read:
The dosing regimen in this study was in accordance with the manufacturer's recommendations: the total cumulative dose was 6610 index of reactivity during the build-up phase, followed by 120 index of reactivity daily.
The authors apologise for any confusion caused by these errors.
